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We evaluated the recovery of cardiovascular function after transient cardiogenic shock. Cardiac tamponade was performed for
1 h and post-shock data were collected in 5 domestic large white female pigs (43 ± 5 kg) for 6 h. The control group (N = 5) was
observed for 6 h after 1 h of resting. During 1 h of cardiac tamponade, experimental animals evolved a low perfusion status with
a higher lactate level (8.0 ± 2.2 vs 1.9 ± 0.9 mEq/L), lower standard base excess (-7.3 ± 3.3 vs 2.0 ± 0.9 mEq/L), lower urinary
output (0.9 ± 0.9 vs 3.0 ± 1.4 mL·kg-1·h-1), lower mixed venous saturation, higher ileum partial pressure of CO2-end tidal CO2
(EtCO2) gap and a lower cardiac index than the control group. Throughout the 6-h recovery phase after cardiac tamponade,
tamponade animals developed significant tachycardia with preserved cardiac index, resulting in a lower left ventricular stroke
work, suggesting possible myocardial dysfunction. Vascular dysfunction was present with persistent systemic hypotension as
well as persistent pulmonary hypertension. In contrast, oliguria, hyperlactatemia and metabolic acidosis were corrected by the
6th hour. The inflammatory characteristics were an elevated core temperature and increased plasma levels of interleukin-6 in
the tamponade group compared to the control group. We conclude that cardiovascular recovery after a transient and severe low
flow systemic state was incomplete. Vascular dysfunction persisted up to 6 h after release of tamponade. These inflammatory
characteristics may also indicate that inflammatory activation is a possible pathway involved in the pathogenesis of cardiogenic
shock.
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Introduction
Cardiogenic shock is an important cause of death,
particularly in patients with acute coronary syndromes
(1,2). In spite of the large number of treatment strategies
that have been tested (3-8), mortality remains high (9) and
thus far only a strategy associated with early myocardial
revascularization has improved the outcome (6).
There are few studies addressing the late response of
the cardiovascular system after a transient hypotensive
episode of cardiac origin. In fact, most of cardiogenic and
obstructive shock studies have emphasized the shock
period with few or no data on the recovery phase (10). A
transient cardiac-induced hypotensive episode could be
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assumed to represent a global ischemia-reperfusion sce-
nario and, as such, be associated with alterations of vascu-
lar function, even after recovery from shock.
A new paradigm in the pathophysiology of cardiogenic
shock has related this disease to the development of
systemic inflammatory response syndrome (SIRS) (11).
According to this hypothesis, in addition to the normal
pathophysiologic process, cardiogenic shock could be as-
sociated with the generation of inflammatory mediators in
the circulation, as well as an overproduction of nitric oxide
(NO) through inducible nitric oxide synthase (NOS) (2).
This would lead to vascular dysfunction and therefore
increase mortality (12). However, the validity of this hypo-
thesis has not been proven. In some studies, a great
subgroup of patients with cardiogenic shock and inflam-
matory response were previously submitted to surgical
revascularization, which could have caused systemic in-
flammatory response per se (11). In addition, experimental
and clinical data also failed to demonstrate any benefit in
unspecific blockade of NOS in acute heart failure and
cardiogenic shock (5,13).
Thus, the aim of this study was to evaluate, in an
experimentally controlled setting, the recovery of the car-
diovascular system after a severe cardiac tamponade-
induced systemic low-flow state for up to 6 h after tampon-
ade relief. A second aim was to determine if a transient
episode of hypotension was associated with the develop-
ment of systemic inflammation.
Material and Methods
This study had previous approval from the Institutional
Animal Research Ethics Committee of Hospital Sírio Libanês
(São Paulo, SP, Brazil) and was performed according to
National Institutes of Health (USA) guidelines for the use of
experimental animals.
Instrumentation and stabilization period
Ten domestic large white female pigs with a body
weight of 43 ± 5 kg were fasted overnight before the
experiment with free access to water. Animals were pre-
medicated with an intramuscular injection of midazolam
(0.3 mg/kg; Dormonid®, Roche, Brazil) and acepromazine
(0.5 mg/kg; Acepran®, Andrômaco, Brazil). Through an
auricular vein, anesthesia was induced with thionembutal
(12 mg/kg; Tiopental®, Abbott, Brazil) and muscular relax-
ation with pancuronium bromide (0.1 mg/kg; Pavulon®,
AKZO Nobel, Brazil). They were then submitted to endo-
tracheal intubation and connected to a mechanical ventila-
tor (Evita 2, Drager, Germany) with the following param-
eters: tidal volume of 8-10 mL/kg, end-expiratory pressure
of 5 cmH2O, inspiratory fraction of oxygen adjusted to keep
arterial saturation between 94 and 96%, and respiratory
rate necessary to keep PaCO2 between 35 and 45 mmHg.
After the end of instrumentation and respiratory param-
eters have been reached, no alterations of ventilatory
parameters were allowed throughout the study. Anesthe-
sia was maintained during the study period with midazo-
lam (0.3 mg·kg-1·h-1), fentanyl citrate (5 µg·kg-1·h-1; Fentanil®,
Janssen-Cilag, Brazil) and muscular relaxation with pan-
curonium bromide (0.2 mg·kg-1·h-1). Supplementary bolus
of 5 µg/kg fentanyl citrate and 0.1 mg/kg pancuronium
bromide were administered, if necessary.
The right external jugular vein was dissected and can-
nulated for introduction of a catheter that was guided to the
pulmonary artery by visualization of pressure curves. The
right femoral artery was dissected and cannulated and a
catheter was inserted to measure continuous arterial pres-
sure and to collect arterial samples. Cystostomy was per-
formed through an inferior laparotomy and a bladder cath-
eter was inserted to measure urinary output. Venous oxim-
etry was calibrated in vivo with a mixed venous sample gas
analysis obtained from the distal port of the pulmonary
arterial catheter.
After monitorization, boluses of 250 mL lactated Ringer’s
solution were used to keep a systemic mean arterial blood
pressure (ABPm) ≥100 mmHg, central venous pressure
(CVP) ≥8 mmHg and mixed venous saturation (SvO2)
≥70% until the end of instrumentation. After the hemody-
namic goals were achieved, amiodarone (5 mg/kg) was
infused for 60 min in both groups to prevent life-threatening
arrhythmias associated with balloon inflation identified in
previous pilot experiments. A midline laparotomy was per-
formed, a tonometry catheter was inserted in the terminal
ileum and the spleen was removed to avoid autotransfusion
during shock (14-16). Through the laparotomy incision, a
diaphragmatic window was opened and the heart and
mediastinum were dissected from the sternum, a plastic
catheter with a rubber balloon was inserted through the
diaphragmatic window, and fixed with a wood stem. Then,
the laparotomy was closed. After instrumentation, an infu-
sion of 5 mL·kg-1·h-1 lactated Ringer’s solution was started
and maintained for all animals throughout the experiment
to avoid hypovolemia. The animals were then allowed to
stabilize without any intervention for 1 h.
ABPm, CVP and pulmonary artery pressure (PAPm)
were measured with quartz transducers (Edwards Critical
Care, USA) and displayed continuously on a multi-modular
monitor (DX 2020, Dixtal, Brazil). Heart rate was measured
with an electrocardiogram, oximetry was placed on the tail
of the animals and end tidal CO2 (EtCO2) sensor was
connected to a line-stream system placed between the
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tracheal tube and the Y piece of the ventilator. All these
measurements were obtained with a DX 2020 multi-modu-
lar monitor. Continuous central venous oximetry was meas-
ured by spectrophotometry and continuous cardiac output
was measured by thermodilution (Vigilance®, Edwards
Lifesciences, USA). Central temperature was obtained
from the thermistor in the pulmonary artery catheter. Ileum
regional CO2 partial pressure was obtained using a 14 F
tonometry catheter (Tonometrics®, Datex-Ohmeda, USA)
and a tonometry monitor (Tonocap®, Datex-Ohmeda).
Shock period
After the stabilization period, 5 animals were randomly
allocated to have the cardiac balloon inflated until systemic
ABPm was between 45 and 55 mmHg. Variations of 10-50
mL of cardiac balloon volume were permitted in order to
maintain systemic ABPm within the pre-specified range for
1 h. Randomization was performed using a box with ten
envelopes in a 5:5 allocation scheme. Animals allocated to
the control group were maintained for one additional hour
in observation.
Before cardiac balloon inflation, hemodynamic data
[heart rate, cardiac output, PAPm, ABPm, CVP, pulmonary
artery occlusion pressure (PAOP), SvO2, urinary output,
ileum regional CO2 partial pressure, EtCO2, core tempera-
ture, arterial blood samples and arterial lactate were col-
lected and recorded as baseline data. During the 1-h
shock period, heart rate, cardiac output, PAPm, ABPm,
CVP, SvO2, ileum regional CO2 partial pressure, and EtCO2
were collected every 10 min in the shock group. After 1 h of
cardiogenic shock-induced hypotension, the cardiac bal-
loon was deflated. Five minutes after cardiac balloon de-
flation, the same variables were measured again and
recorded as post-shock results. In the control group, data
were collected at baseline and post-shock.
Post-shock and 6-h observation period
After the shock period, animals were observed for 6 h
to characterize this period regarding hemodynamic, meta-
bolic and inflammatory variables. Hemodynamic data (heart
rate, cardiac output, PAPm, ABPm, CVP, PAOP), ileum
regional CO2 partial pressure, EtCO2, core temperature,
arterial blood sample and arterial lactate were collected at
1, 3, and 6 h after cardiac balloon deflation. Urinary output
was measured at the end of each hour. Blood samples
were obtained to measure interleukin-6 concentrations at
baseline, 3 and 6 h and stored at -80°C until laboratory
measurement. At the end of the 6th hour, a thoracotomy
was performed, heart and lungs were macroscopically
inspected and animals were then sacrificed with an intra-
venous bolus injection of 20 mL potassium chloride.
Laboratory analysis
Blood gas, hemoglobin (used in the mixed venous
hemoglobin saturation monitor calibration), standard base
excess and lactate analysis were performed in a blood gas
analyzer (ABL 700 Radiometer, Denmark). Cytokine con-
centration in plasma was measured with specific commer-
cially available enzyme-linked immunosorbent assay kits
according to manufacturer instructions (R&D Systems,
USA).
Calculations
To calculate hemodynamic variables extracted from
the pulmonary artery catheter monitorization, standard
formulas were used (17). Parameters whose units are not
given in the tables are as follows: a) systemic vascular
resistance index (dynes·s-1·(cm5)-1·kg-1) = (ABPm - CVP) x
80 / CI; b) left ventricular stroke work index [(mL x mmHg)
/ (kg x beat)] = (ABPm - PAOP) x SI x 0.0136, where SI =
stroke index and CI = cardiac index.
Statistical analysis
Data were considered to be normal using the Shapiro-
Wilk goodness of fit model, and are reported as mean ±
standard deviation. Single means were compared with the
Student t-test and a P ≤ 0.05 was considered to be signifi-
cant. Means within groups and between groups as well as
the factor x time interaction during the evolution over time
were analyzed using two-way ANOVA. Bonferroni’s cor-
rection for multiple comparisons was used with two-way
ANOVA, and for five time point comparisons (baseline,
post-shock, 1, 3, and 6 h) significance was considered to
be P ≤ 0.01 for the three levels of the analysis (between,
within and factor x time interaction). The commercially
available SPSS 10.0 (USA) statistical software package
was used.
Results
Shock period
The cardiac balloon was initially inflated with 8.0 ± 4.9
mL/kg of room air, and variations in the balloon volume
were performed to keep the systemic ABPm within the pre-
set range. Physiological data during the shock period are
reported in Table 1.
During shock, transient cardiac tamponade induced a
sustained decrease in cardiac index and mixed venous
saturation, as well as an important increase in ileal CO2-
EtCO2 gap. Lactate increased 4-fold during shock and
standard base excess decreased consistently during shock
(Table 1). These data are consistent with severe systemic
hypoperfusion during cardiac tamponade.
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Table 1. Physiological data obtained during the cardiac tamponade shock period.
Variable Baseline 10 min 20 min 30 min 40 min 50 min 60 min Post-shock
Balloon volume (mL/kg)
Control 0 0 0 0 0 0 0 0
Shock 0 8.0 ± 4.9 12.8 ± 9.1 13.5 ± 5.5 16.0 ± 5.1 16.6 ± 7.4 14.6 ± 7.6 0
Cardiac index (mL·kg-1·min-1)
Control 157 ± 38 - - - - - - 149 ± 21
Shock 152 ± 37 94 ± 49 77 ± 37 65 ± 37 66 ± 31 64 ± 25 63 ± 20 84 ± 19
Heart rate (bpm)
Control 107 ± 14 - - - - - - 101 ± 9
Shock 103 ± 2 137 ± 27 153 ± 35 178 ± 22 193 ± 14 202 ± 23 202 ± 29 176 ± 26
ABPm (mmHg)
Control 110 ± 14 - - - - - - 114 ± 7
Shock 110 ± 17 50 ± 3 49 ± 5 47 ± 4 49 ± 3 48 ± 2 49 ± 3 75 ± 11
PAPm (mmHg)
Control 26 ± 5 - - - - - - 27 ± 6
Shock 28 ± 4 26 ± 2 27 ± 3 29 ± 3 29 ± 3 31 ± 4 31 ± 3 35 ± 8
CVP (mmHg)
Control 9 ± 3 - - - - - - 11 ± 3
Shock 11 ± 3 14 ± 5 14 ± 5 14 ± 6 14 ± 5 15 ± 5 11 ± 3 11 ± 3
PAOP (mmHg)
Control 11 ± 4 - - - - - - 11 ± 5
Shock 12 ± 2 - - - - - - 11 ± 3
SvO2 (%)
Control 74 ± 6 - - - - - - 72 ± 5
Shock 73 ± 8 42 ± 11 41 ± 7 37 ± 5 40 ± 5 35 ± 4 37 ± 7 64 ± 7
EtCO2 (mmHg)
Control 35 ± 3 - - - - - - 38 ± 2
Shock 38 ± 2 32 ± 2 31 ± 5 32 ± 2 34 ± 2 35 ± 3 37 ± 4 47 ± 6
SBE (mEq/L)
Control 1.2 ± 1.6 - - - - - - 2.0 ± 0.9
Shock 3.7 ± 0.8 - - - - - - -7.3 ± 3.3
PrCO2 - EtCO2 (mmHg)
Control 22 ± 9 - - - - - - 23 ± 9
Shock 20 ± 6 30 ± 6 39 ± 9 45 ± 12 48 ± 16 48 ± 17 49 ± 18 48 ± 17
Lactate (mmol/L)
Control 1.8 ± 1.5 - - - - - - 1.9 ± 0.9
Shock 1.7 ± 0.7 - - - - - - 8.0 ± 2.2
Urinary output (mL·kg-1·h-1)
Control 4.6 ± 2.4 - - - - - - 3.0 ± 1.4
Shock 3.7 ± 1.4 - - - - - - 0.9 ± 0.9
Data are reported as means ± SD for 5 domestic large female pigs in each group. A dash indicates that the data were not collected.
ABPm = systemic mean arterial blood pressure; PAPm = mean pulmonary artery blood pressure; CVP = central venous pressure;
PAOP = pulmonary artery oclusion pressure; SvO2 = oxygen mixed venous saturation; EtCO2 = end tidal CO2 pressure; SBE =
standard base excess; (PrCO2 - EtCO2) = tissue-arterial CO2 gap.
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Post-shock and 6-h observation period
All physiological data of both groups are shown in
Figures 1 to 3 and Table 2. The amount of lactated Ringer’s
solution received during the 6 h of observation, 1350 ± 189
mL for the shock group, was not statistically different from
1200 ± 99 mL for the control group.
After tamponade, shock animals developed myocar-
dial dysfunction lasting for 6 h, as observed by statistically
significant decrease in stroke index and left ventricular
work index, as well as a significant increase in heart rate
(Figure 1). Transitory shock also induced sustained pul-
monary hypertension and a late significant increase in
CVP when compared to control animals (Figure 2). Other
signs of cardiovascular dysfunction were the reduction in
systemic ABPm with time in the shock group (Figure 2) and
a significant decrease in mixed venous saturation after 3
and 6 h of relief of tamponade in the shock group com-
pared to baseline (Figure 3).
Transient cardiac tamponade also induced inflamma-
tory disturbances. Pigs submitted to shock developed
significant hyperthermia compared to controls (Figure 3).
IL-6, a cytokine clearly related to inflammatory processes,
was increased significantly after 3 and 6 h in cardiac
tamponade animals compared to baseline, thus suggest-
ing that inflammatory changes could be related to cardio-
genic shock.
The anatomic macroscopic appearance of the lungs
and heart at the end of the observation period was normal
and similar in all animals.
Discussion
This study demonstrates, for the first time, that severe
and transient cardiogenic shock-induced hypodynamic
states are associated with posterior persistent cardiovas-
cular dysfunction and induction of inflammatory distur-
bances. These data also emphasize the obvious need for
prompt treatment of hypotension in cardiogenic and ob-
structive shock in order to avoid the generation of inflam-
matory mediators that can be associated with the develop-
Table 2. Physiologic data during the 6-h observation period after cardiac tamponade.
Variable Baseline Post shock 1 h 3 h 6 h P Factor-time
interaction
PAOP (mmHg)
Control 11 ± 4 11 ± 5 9 ± 2 9 ± 2 7 ± 2
Shock 12 ± 2 11 ± 3 12 ± 4 10 ± 1 9 ± 1 -
PO2/FiO2 ratio
Control 401 ± 100 413 ± 72 417 ± 89 342 ± 59 331 ± 52
Shock 365 ± 51 296 ± 60 299 ± 75 301 ± 63 304 ± 46 -
EtCO2 (mmHg)
Control 35 ± 3 38 ± 2 37 ± 2 39 ± 2 38 ± 4   0.461
Shock 38 ± 2 47 ± 6 45 ± 4 41 ± 2 39 ± 2 -
SBE (mEq/L)
Control 1.2 ± 1.6 2.2 ± 0.9 2.8 ± 0.8 2.1 ± 0.8 3.8 ± 2 <0.001 <0.001
Shock 3.7 ± 0.8 -7.3 ± 3.3 -3.1 ± 3.2 1.8 ± 2.1 3.3 ± 0.7 <0.001 -
PrCO2 - EtCO2 (mmHg)
Control 22 ± 9 23 ± 9 27 ± 8 29 ± 11 35 ± 2   0.039
Shock 20 ± 6 48 ± 17 35 ± 4 38 ± 5 28 ± 9 -
Lactate (mmol/L)
Control 1.8 ± 1.5 1.9 ± 0.9 1.4 ± 0.5 1.8 ± 1.4 1.5 ± 0.6 <0.001 <0.001
Shock 1.7 ± 0.7 8.0 ± 2.2 5.6 ± 2.4 2.6 ± 2.1 1.6 ± 0.1 <0.001 -
Urinary output (mL·kg-1·h-1)
Control 4.6 ± 2.4 3.0 ± 1.4 2.4 ± 1.5 3 ± 1.6 1.2 ± 0.4 <0.019
Shock 3.7 ± 1.4 0.9 ± 0.9 0.6 ± 0.4 1 ± 0.4 1 ± 0.4 <0.033 -
Data are reported as means ± SD for 5 domestic large female pigs in each group. A dash indicates that the data were not calculated.
Control group data were analyzed by two-way between analysis ANOVA and shock group data were analyzed by two-way within
analysis ANOVA. PO2/FiO2 denotes oxygen partial pressure over inspiratory oxygen fraction ratio. Other abbreviations are defined in
the legend to Table 1.
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Figure 1. Evolution of hemodynamic parameters of pigs after cardiac tamponade shock. Filled circles = shock group; open triangles
= control group. Panel A, cardiac index (two-way ANOVA: P = 0.378, between analysis; P = 0.186, within analysis and P = 0.148,
factor x time interaction). Panel B, heart rate (two-way ANOVA: P < 0.001, between analysis; P < 0.001, within analysis and P < 0.001,
factor x time interaction). Panel C, stroke index over time (two-way ANOVA: P < 0.001, between analysis x time interaction). Panel D,
left ventricular stroke work index (two-way ANOVA: P < 0.001, between analysis; P < 0.001, within analysis and P < 0.001, factor x
time interaction). Data are reported as means ± SD for 5 pigs in each group. *P < 0.05 vs control group (Tukey post hoc analysis). +P
< 0.05 vs baseline (Tukey post hoc analysis).
ment of multiple organ failure (18).
This cardiogenic shock-induced systemic low flow
model was planned to reach an ABPm of 45-55 mmHg. As
shown in Table 1, the values of ABPm were close to 50
mmHg during the shock period and hypotension was asso-
ciated with an important reduction of stroke index. Signs of
tissue hypoxia during and after the shock period are clearly
indicated by high ileum partial pressure of CO2-EtCO2 gap,
low SvO2 levels and hyperlactatemia associated with meta-
bolic acidosis. On this basis, the efficacy of the model for
causing a real period of cardiogenic shock is remarkable.
Cardiogenic shock is caused by decreased systemic
cardiac output in the presence of adequate intravascular
volume resulting in tissue hypoxia (1). In experimental
studies of this condition in which no treatment is instituted,
death is attributed to the progressive failure of the left
ventricular pump to maintain cardiac output and systemic
pressures (19). The fatal course of cardiogenic shock is
traditionally ascribed to a so-called downward spiral of
events associated with the activation of compensatory
mechanisms, such as the sympathetic nervous system
and the renin-angiotensin system, resulting in an increase
in heart rate and contractility that raises myocardial oxy-
gen demand and worsens myocardial ischemia, and vaso-
constriction that increases myocardial afterload (20). How-
ever, Lim et al. (21) have described that 45% of patients
admitted with cardiogenic shock to a mixed intensive care
unit died with a normal cardiac index and low or normal
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systemic vascular resistance index. Among those patients,
only half of them had evidence of infection. The authors
concluded that it could be necessary to reevaluate the
spiral model of the fatal course of cardiogenic shock.
A large subgroup of patients with cardiogenic shock
after myocardial infarction showed clinical signs of severe
systemic inflammation (22), and those who were culture
positive for sepsis had twice the risk of death (11). Obser-
vation of lower systemic vascular resistance at the onset of
shock in patients who subsequently had culture-positive
systemic inflammation suggests that inappropriate vasodi-
lation may play an important role in the pathogenesis and
persistence of shock (2,11).
In the present study, the presence of relative hypoten-
sion with a preserved cardiac index points to vasodilatory
shock. The absence of difference in the evolution of the
calculated systemic vascular resistance index between
the tamponade and control groups could be explained by a
low severity vasodilation or by relative hypovolemia caused
by the increase in systemic oxygen consumption and
hyperthermia. The pathogenesis of vasodilation in cardio-
genic shock has been attributed to the release of inflam-
matory cytokines with subsequent production of NO by
inducible NOS (2). In some clinical studies, the development
of SIRS criteria and the production of inflammatory media-
tors after cardiogenic shock have been associated with
Figure 2. Systemic hemodynamic and perfusional features of pigs during the study. Filled circles = shock group; open triangles =
control group. Panel A, systemic mean arterial pressure over time (two-way ANOVA: P < 0.001, between analysis; P < 0.001, within
analysis and P = 0.029, factor x time interaction). Panel B, systemic vascular resistance index during the study (two-way ANOVA: P
= 0.223, between analysis; P = 0.700, within analysis and P = 0.252, factor x time interaction). Panel C, pulmonary mean arterial
pressure over time (two-way ANOVA: P < 0.001, between analysis; P = 0.589, within analysis and P = 0.422, factor x time interaction).
Panel D, central venous pressure (two-way ANOVA: P = 0.007, between analysis; P = 0.545, within analysis and P = 0.536, factor x
time interaction). Data are reported as means ± SD for 5 pigs in each group. *P < 0.05 vs control group (Tukey post hoc analysis). +P
< 0.05 vs baseline (Tukey post hoc analysis).
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Figure 3. Perfusion and inflammatory features of pigs during the
study. Filled circles = shock group; open triangles = control
group. Panel A, hemoglobin mixed venous saturation over time
(two-way ANOVA: P = 0.023, between analysis; P = 0.002,
within analysis and P = 0.701, factor x time interaction). Panel B,
core temperature over time (two-way ANOVA: P = 0.023, be-
tween analysis; P = 0.002, within analysis and P = 0.701, factor x
time interaction). Panel C, serum concentration of interleukin 6
(two-way ANOVA: P < 0.001, between analysis; P < 0.001,
within analysis and P = 0.070, factor x time interaction). Data are
reported as means ± SD for 5 pigs in each group. *P < 0.05 vs
control group (Tukey post hoc analysis). +P < 0.05 vs baseline
(Tukey post hoc analysis).
multiple organ failure and increased mortality (11,12,18).
However, there are few experimental studies supporting
these clinical data and in clinical trials some bias may have
affected the interpretation of the data. For instance, in the
subgroup analysis of the SHOCK study, a significant number
of patients reported with SIRS criteria were previously sub-
mitted to coronary artery bypass graft, a condition largely
associated with inflammatory activation (11).
In this model, besides hypotension, a possible myocar-
dial dysfunction marked by preserved cardiac index with
elevated heart rate and low stroke index occurred, result-
ing in a low left ventricular stroke work index. It could be
associated with the induced inflammatory syndrome (23).
However, it is hard to affirm that inflammatory activation
was the only factor responsible for this myocardial depres-
sion.
Other controversial results came from studies that evalu-
ated NO role in this scenario. Unspecific NOS blockade
was not able to restore cardiovascular function in experi-
mental coronary microembolization (13) nor did its block-
ade demonstrate any benefit in reducing the mortality in a
large clinical study (5), despite previous results from small
trials (3,4). Our study demonstrates partially that the in-
flammatory response acts as a pathway associated with
cardiogenic shock and adds new information by demon-
strating that even transient hypotension is followed by
prolonged vascular dysfunction. The controlled experi-
mental setting of this study may also eliminate some of the
bias observed in clinical trials and therefore may be useful
for future studies of systemic hemodynamics and thera-
peutics in hypodynamic shock.
Our study has some limitations: First, the spleen was
removed and it can be responsible for the modulation
(amplification) of extra spleen cytokine production in dogs
(24). Second, from the statistic viewpoint, many compari-
sons can be underpowered using two-way ANOVA with
Bonferroni’s correction for multiple comparisons. Third,
the time spent in shock (1 h) may not have been sufficient
to trigger a clinically important inflammatory response in
order to cause absolute hypotension after shock.
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